1. Signaling Pathways
  2. Cell Cycle/DNA Damage
    Stem Cell/Wnt
  3. Casein Kinase
  4. Casein Kinase Inhibitors

Casein Kinase Inhibitors

CK1

CK2

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

Casein Kinase Inhibitors
Product Name CK1 CK2 Purity
Silmitasertib  
CK2α, IC50: 1 nM
CK2α', IC50: 1 nM
99.92%
IWP-2
CK1δ, IC50: 40 nM
  99.51%
Emodin  
CK2α Wild-type, IC50: 5.9 μM (at ATP concentration is 50 μM)
CK2α Wild-type, IC50: 1.4 μM (at ATP concentration is 10 μM)
99.39%
Ellagic acid  
CK2, IC50: 40 nM
99.92%
ALV1
CK1α
 
LY294002 hydrochloride  
CK2α2, IC50: 3.869 μM
CK2, IC50: 0.098 μM
Umbralisib sulfate
CK1ϵ, Kd: 180
 
D4476
CK1, IC50: 0.3 μM
  99.51%
Umbralisib
CK1ϵ, EC50: 6.0 μM
CK1ϵ, Kd: 180 nM
  98.69%
TBB  
CK2, IC50: 0.15 μM (Human CK2)
99.31%
Silmitasertib sodium salt  
CK2α, IC50: 1 nM
CK2α', IC50: 1 nM
99.91%
PF-670462
CKIδ, IC50: 14 nM
CKIϵ, IC50: 7.7 nM
  99.96%
TAK-715
CK1ϵ
CK1δ
  99.89%
DMAT  
CK2, IC50: 0.13 μM (Human CK2)
98.03%
SR-3029
CKIδ, IC50: 44 nM
CKIϵ, IC50: 260 nM
  99.05%
IC261
CKIδ, IC50: 1 μM
CKIϵ, IC50: 1 μM
CkIα1, IC50: 16 μM
  99.75%
CKI-7 free base
CK1, IC50: 6 μM
CK1, Ki: 8.5 μM
  99.34%
PF-4800567
CK1ϵ, IC50: 32 nM
CKIδ, IC50: 711 nM
  98.00%
Hematein  
CKII, IC50: 0.74 μM
TTP 22  
CK2, IC50: 100 nM
98.03%
Casein Kinase inhibitor A51
CKIα
  98.42%
Longdaysin
CKIδ, IC50: 8.8 μM
CKIα, IC50: 5.6 μM
  99.87%
CK1-IN-1
CK1ϵ, IC50: 16 nM
CKIδ, IC50: 15 nM
  98.70%
NCC007
CKIδ, IC50: 3.6 μM
CKIα, IC50: 1.8 μM
  99.73%
BioE-1115  
CK2α, IC50: 10 μM
98.08%
TA-01
CKIδ, IC50: 6.8 nM
CKIϵ, IC50: 6.4 nM
  99.77%
MRT00033659
CKIδ, IC50: 0.9 μM
  99.18%
AMG-548 dihydrochloride
CK1
  ≥98.0%
TBCA  
CK2, IC50: 110 nM
CK2, Ki: 77 nM
99.60%
PI-828  
CK2α2, IC50: 1.127 μM
CK2, IC50: 149 nM
99.09%
LH846
CKIδ, IC50: 290 nM
CKIϵ, IC50: 1.3 μM
CKIα, IC50: 2.5 μM
  ≥98.0%
TMX-4116
CK1α
  99.50%
FPFT-2216
CK1α
  99.35%
A-3 hydrochloride
CK1, Ki: 80 μM
CK2, Ki: 5.1 μM
99.67%
CK2/ERK8-IN-1  
CK2, IC50: 0.5 μM
CK2, Ki: 0.25 μM
≥99.0%
CK2 inhibitor 2  
CK2, IC50: 0.66 nM
98.12%
Casein Kinase inhibitor A86
CKIα
  98.47%
Umbralisib hydrochloride
CKIϵ, EC50: 6 μM
CKIϵ, Kd: 180 nM
  98.98%
SGC-CK2-1  
CK2α, IC50: 36 nM
CK2α', IC50: 16 nM
99.41%
AMG-548
CK1
  ≥99.0%
TMX-4113
CK1α
  98.66%
BRD4/CK2-IN-1  
CK2, IC50: 230 nM
CKI-7
CK1, IC50: 6 μM
CK1, Ki: 8.5 μM
 
Ellagic acid (hydrate)  
CK2, IC50: 40 nM
CK2, Ki: 20 nM
PF-5006739
CK1ϵ, IC50: 17.0 nM
CK1δ, IC50: 3.9 nM
 
CK2/PIM1-IN-1  
CK2, IC50: 3.787 μM
AMG-548 hydrochloride
CK1
 
SR-1277
CKIδ, IC50: 49 nM
CKIϵ, IC50: 260 nM
 
EGFR-IN-57  
CK2α, IC50: 0.171 μM
Quinalizarin  
CK2, IC50: 110 nM
CK2, Ki: ~50 nM
TMCB  
CK2α, Ki: 83 nM
CK2α', Ki: 21 nM
CK2 inhibitor 3  
CK2, IC50: 280 nM
4,5,6,7-Tetrabromo-1H-benzimidazole  
CK2